Skip to main content
SpringerLink
Log in

Academic clinician–scientists risk becoming an endangered species

  • World View
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Barriers to their training and retention threaten medical research

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gill, G. N. Am. Scholar 53, 353–368 (1984).

    Google Scholar 

  2. Kwan, J. M. & Gross, C. P. JAMA Netw. Open 6, e2332982 (2023).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MRC Metabolic Diseases Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK

    Stephen O’Rahilly

  2. NIHR Cambridge Biomedical Research Centre, Cambridge, UK

    Stephen O’Rahilly

Authors
  1. Stephen O’Rahilly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen O’Rahilly.

Ethics declarations

Competing interests

In the past 2 years, S.O.R. has provided consultancy services to Pfizer, AstraZeneca, Northsea Therapeutics, Third Rock Ventures and Medicxi and received research support from GSK.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Rahilly, S. Academic clinician–scientists risk becoming an endangered species. Nat Med 29, 2989 (2023). https://doi.org/10.1038/s41591-023-02626-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-023-02626-8

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation